Breast cancer experts are hailing what could be some of the biggest advances in more than a decade – two new medicines that significantly delay the time until women with very advanced cases get worse.

Women with early breast cancer who are treated with the drug Herceptin have almost a 50% reduced risk of the disease returning, according to research published today.